SII, Department of Biotechnology to launch India's first qHPV vaccine against cervical cancer tomorrow Ruchika Sharma31 Aug 2022 2:52 PM IST"It is very effective and prevents cervical cancer because, 85 percent to 90 percent cases, cervical cancer is because of this particular virus and...
Centre plans to roll out SII qHPV vaccine for girls aged 9-14 years under National Immunization Programme Ruchika Sharma11 Aug 2022 4:30 PM ISTCervical cancer can be prevented by vaccinating girls in the age group of 9-14 years with HPV vaccine, the sources said.
Serum Institute to supply 1 crore qHPV vaccine doses by December: Sources Ruchika Sharma2 Aug 2022 11:34 AM ISTCervical cancer in India ranks as the second most frequent cancer among women aged between 15 and 44 years.
SII to launch QHPV vaccine against cervical cancer Rahul Verma14 July 2022 10:42 AM ISTIndia's first Quadrivalent Human Papillomavirus vaccine (qHPV) against cervical cancer gets Drugs Controller General of India's (DCGI) approval for...
FIRST: Serum Institute gets DCGI nod for qHPV vaccine against cervical cancer Ruchika Sharma13 July 2022 11:37 AM ISTThe National Technical Advisory Group on Immunisation (NTAGI) had recently also approved the qHPV after reviewing the clinical trial data of the...
DCGI recommends allowing Serum Institute to manufacture, stockpile QHPV vaccine Rahul Verma8 July 2022 5:30 PM ISTThe Drugs Controller General of India has recommended allowing Serum Institute of India to manufacture and stockpile their life-saving qHPV vaccine...
DCGI recommends allowing SII to manufacture, stockpile life-saving qHPV vaccine against cervical cancer Ruchika Sharma7 July 2022 1:30 PM ISTCervical cancer is the second-most frequent type of the disease in India among women aged between 15 and 44 years.
Govt advisory panel to review trial data on Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma27 Jun 2022 11:29 AM ISTNew Delhi: The government advisory panel NTAGI is likely to review on June 28 trial data on India's first quadrivalent human papillomavirus (qHPV)...
CDSCO panel recommends market nod for Serum Institute qHPV vaccine against cervical cancer Ruchika Sharma16 Jun 2022 1:45 PM ISTIn the application, Singh is learnt to have stated that qHPV vaccine CERVAVAC has demonstrated robust antibody response that is nearly 1,000 times...
SEC to review Serum Institute qHPV vaccine trial data today Ruchika Sharma15 Jun 2022 11:20 AM ISTNew Delhi: The first indigenously developed quadrivalent human papillomavirus (qHPV) vaccine against cervical cancer by the Serum Institute of India...
Serum Institute seeks DCGI nod to manufacture qHPV vaccine Cervavac against cervical cancer Ruchika Sharma9 Jun 2022 12:39 PM IST"This will fulfill the dream of our hon'ble Prime Minister Narendra Modi 'VOCAL FOR LOCAL' and 'MAKING IN INDIA FOR THE WORLD' and will ensure...
SII to seek DCGI market nod for qHPV vaccine against cervical cancer Dr. Nandita Mohan16 May 2022 5:26 PM ISTThe Serum Institute of India (SII) has sought the government's permission to manufacture and stockpile indigenously developed Quadrivalent Human...
